市场调查报告书
商品编码
1132004
3D 打印药品全球市场规模研究,按技术,按应用,按最终用途,按地区预测 2022-2028Global 3D Printed Drugs Market Size study, by Technology, By Application, By End-use and Regional Forecasts 2022-2028 |
2021 年全球 3D 打印药品市场价值约为 7202 万美元,预计在 2022-2028 年的预测期内以超过 15.30% 的健康增长率增长。
3D 打印药物是通过 3D 打印过程创建的处方,旨在为个人提供安全、有效和量身定制的药物。这些药物不需要整个吞服,因为它们的一体式多孔结构很容易在口腔中分散。这使生产商可以轻鬆修改不同药物的大小、形状、外观和分布动力学。由于对个性化医疗的需求不断增长,以及支持 3D 打印的研发活动迅速扩大,市场正在蓬勃发展。这项技术通过实现个性化医疗为改善患者护理创造了有希望的机会。为了使药物更安全、更有效,自 2015 年美国个性化医学倡议成立以来,製药研究公司也一直在寻求开发更专业的治疗方法。因此,预计未来几年对 3D 打印药品的需求将会增长。增加运营商对生产先进有效的 3D 打印药品的投资以及 3D 打印技术的突破预计将在预测期内推动市场增长。例如,CurfiyLabs 和 Natural Machines 于 2022 年 3 月合作,根据患者的个体需求生产这些药物。希望这将使药店和医院能够更快地收到药品。然而,这些药物的副作用、使用 3D 打印机开发非法药物以及政府对 3D 打印机产品缺乏监管等都是阻碍市场扩张的因素。另一方面,随着新兴国家医疗保健系统和技术的突破,人们对这些药物的快速溶解等益处的普遍认识有望为市场扩张创造广阔的潜力。
全球 3D 打印药品市场研究考虑的主要地区是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。亚太地区在 3D 打印药物市场拥有最大的市场份额,预计在预测期内将以健康的复合年增长率增长。医疗基础设施的快速发展和医疗研发投资的增加预计将推动亚太地区 3D 打印药品市场的增长。由于欧洲人的健康意识不断增强,预计欧洲地区在预测期内也将实现令人满意的增长。
本报告中包含的主要市场参与者是:
本研究的目的是确定近年来各个细分市场和国家/地区的市场规模,并预测未来 8 年的价值。该报告旨在包括按地区和国家研究的行业的定性和定量方面。此外,它还提供了有关关键方面的详细信息,例如定义市场未来增长的驱动因素和挑战。此外,报告还应详细分析主要参与者的竞争格局和产品供应,以及微观市场中可供利益相关者投资的机会。市场的详细细分和子细分如下所述。
按技术
喷墨打印
熔融增材製造
立体光刻
ZipDose 技术
按应用程序
骨科
神经
牙科
杂项
按最终用户
医院/诊所
研究所
杂项
按地区
北美
美国
加拿大
欧洲
英国
德国
法国
西班牙
意大利
其他欧洲
亚太地区
中国
印度
日本
澳大利亚
韩国
其他亚太地区
拉丁美洲
巴西
墨西哥
世界其他地方
此外,本研究考虑的年份是:
实际年份 - 2018 年、2019 年、2020 年
2021 年基准年
预测期 - 2022 年 至 2028 年
本报告的目标受众是全球 3D 打印药品市场。
主要咨询公司和顾问
大公司、中型公司、中小企业
风险投资
增值经销商 (VAR)
第三方知识提供者
投资银行家
投资者
Global 3D Printed Drugs Market is valued at approximately USD 72.02 million in 2021 and is anticipated to grow with a healthy growth rate of more than 15.30% over the forecast period 2022-2028. 3D printed drugs are prescriptions created with the 3D printing process to provide individuals with safe and effective tailored medications. These drugs don't need to be swallowed whole because of the unitary porous architecture that makes it simple for them to scatter in the mouth. It makes it simple for producers to alter the size, shape, appearance, and rate of distribution of a variety of medications. The market is booming as a result of rising demand for personalized drugs and rapidly expanding R&D activities supporting 3D printing. By producing personalized medical therapies, this technology creates promising opportunities for improving patient care. To make pharmaceuticals safer and more effective, pharmaceutical research companies have also been looking into the development of more specialised remedies since the establishment of the United States Personalized Medicine Initiative in 2015. As a result, demand for 3D-printed drugs is expected to increase in the coming years.Increased investments by operating players in the production of advanced and effective 3D printed pharmaceuticals, as well as breakthroughs in 3D printing technology, are expected to drive market growth over the forecast period. CurfiyLabs and Natural Machines, for example, collaborated in March 2022 on the production of these medicines based on the needs of individual patients. This is expected to allow pharmacies and hospitals to receive medications more quickly. However, the adverse effects of these drugs, the development of illicit drugs using 3D printing and the absence of government restrictions for 3D printed goods are two factors that are limiting market expansion. On the other hand, growing public knowledge of the advantages of these medications, such as their rapid solubility, along with breakthroughs in healthcare systems and technology in emerging nations, are anticipated to create a wide range of potential for market expansion.
The key regions considered for the global 3D Printed Drugs market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific has the largest market share in the 3D printed drugs market and is expected to grow at a healthy CAGR during the forecast period. Rapid development of healthcare infrastructure and increased investment in healthcare research and development are expected to drive the growth of the Asia Pacific 3D printed drugs market. The Europe region is also expected to grow satisfactorily during the forecast period, owing to rising health consciousness among Europeans.
Major market players included in this report are:
Extend Biosciences
BioDuro
Affinity Therapeutics
Osmotica Pharmaceuticals
Aprecia Pharmaceuticals LLC
GlaxoSmithKline Plc
FabRx Ltd
Hewlett Packard Caribe
Merck
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByTechnology:
Inkjet Printing
Fused Deposition Modeling
Stereolithography
ZipDose Technology
By Application:
Orthopedic
Neurology
Dental
Others
By End-use:
Hospitals & clinics
Research Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global 3D Printed Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures